Exagen Inc.
Status: Publicly traded
Direct answer
Exagen Inc. is publicly traded on NASDAQ under the ticker XGN.
Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States. The company's mission is to equip rheumatologists with advanced tools for the precise diagnosis, prognosis, and ongoing management of autoimmune and related diseases, including systemic lupus erythematosus...
Can you invest in Exagen Inc.?
Yes. Exagen Inc. trades publicly on NASDAQ as XGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.